Results 151 to 160 of about 6,409,464 (276)
Dynamic Model Selection in a Hybrid Ensemble Framework for Robust Photovoltaic Power Forecasting. [PDF]
Song N, Chang-Silva R, Lee K, Park S.
europepmc +1 more source
Erratum: Permittivity Model Selection Based on Size and Quantum-Size Effects in Gold Films
Iuliia Riabenko +3 more
openalex +1 more source
The Selection and Improvement of China's Financial Regulatory Model under the Financial Crisis [PDF]
Shuo Ai
openalex +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Two forecasting model selection methods based on time series image feature augmentation. [PDF]
Jiang W, Wang Q, Li H.
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing. [PDF]
van Os W +7 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Deep Ensemble Learning for Application Traffic Classification Using Differential Model Selection Technique. [PDF]
Baek UJ +4 more
europepmc +1 more source

